Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 6/20 | 0.92 |
| ▸ | TSHR | P16473 | 3/20 | 0.92 |
| ▸ | LMNA | P02545 | 1/20 | 0.92 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.92 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.54 |
| ▸ | HPGD | P15428 | 2/20 | 0.50 |
| ▸ | CES2 | O00748 | 1/20 | 0.46 |
| ▸ | CES1 | P23141 | 1/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | NPC1 | O15118 | 2/20 | 0.40 |
| ▸ | RAB9A | P51151 | 2/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.40 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.40 |
| ▸ | RELA | Q04206 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Toluene SCHEMBL10861620 | 1.00 | — | — | |
| SCHEMBL12344943 | 0.96 | ACHE (1.00) | ACHETSHRLMNAALOX12TDP1 | |
| SCHEMBL12344964 | 0.96 | ACHE (1.00) | ACHETSHRLMNAALOX12TDP1 | |
| Toluene SCHEMBL4429042 | 0.96 | ACHE (1.00) | ACHETSHRLMNAALOX12TDP1 | |
| Toluene SCHEMBL8433895 | 0.96 | ACHE (1.00) | ACHETSHRLMNAALOX12TDP1 | |
| Toluene SCHEMBL10976206 | 0.96 | ACHE (1.00) | ACHETSHRLMNAALOX12TDP1 | |
| Toluene SCHEMBL11213676 | 0.96 | ACHE (1.00) | ACHETSHRLMNAALOX12TDP1 | |
| Toluene SCHEMBL1 | 0.96 | — | — | |
| Toluene SCHEMBL5665166 | 0.96 | ACHE (1.00) | ACHETSHRLMNAALOX12TDP1 | |
| Toluene SCHEMBL175861 | 0.96 | ACHE (1.00) | ACHETSHRLMNAALOX12TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025245301-A1 | HIGH PURITY BIS (ARENE) METAL COMPLEXES | ENTEGRIS, INC. (US) | 2025-11-27 | — | — | WO | disclosed |
| US-20250361254-A1 | HIGH PURITY BIS (ARENE) METAL COMPLEXES | ENTEGRIS INC (US) | 2025-11-27 | — | — | US | disclosed |
| EP-4476233-A1 | ORGANOMETALLIC PRECURSORS AND RELATED METHODS | Entegris, Inc. (US) | 2024-12-18 | — | — | EP | disclosed |
| CN-118804919-A | Organometallic precursors and related methods | 恩特格里斯公司 | 2024-10-18 | — | — | CN | disclosed |
| US-20230271987-A1 | ORGANOMETALLIC PRECURSORS AND RELATED METHODS | ENTEGRIS, INC. | 2023-08-31 | — | — | US | disclosed |
| WO-2023154404-A1 | ORGANOMETALLIC PRECURSORS AND RELATED METHODS | ENTEGRIS, INC. (US) | 2023-08-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250361254-A1 | HIGH PURITY BIS (ARENE) METAL COMPLEXES | FHIT, AP2M1, AP1M1 | ACHE 3012/4885TSHR 4751/4885LMNA 1101/4885 |
| US-20230271987-A1 | ORGANOMETALLIC PRECURSORS AND RELATED METHODS | APC, TPR, INTS9 | ACHE 1989/4885TSHR 4662/4885LMNA 2072/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.